Nanostim signs investment deal with St. Jude

Milpitas, CA-based Nanostim has reached an agreement with St. Jude Medical, which has committed to a staged financing of the pacemaker developer, subject to it achieving certain development and clinical milestones. The agreement also gives St. Jude Medical the exclusive option to acquire the company. Nanostim release

Suggested Articles

Takeda tapped Roche’s Foundation Medicine to develop tissue- and blood-based companion diagnostic tests for its portfolio of lung cancer therapies.

Cellex has announced plans to develop a rapid coronavirus test that people can fully perform at home, from sample collection to result, using an app.

More than 20 states either don’t release or have incomplete data on the rapid antigen tests now considered key to containing the coronavirus.